Kisqali 200 MG daily dose UU 21S
Ended Awarded
- Contract number
- SPE2DB25FCZKW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,613
Award facts
- Contract value 100% obligated
- $25,612.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,612.79 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Kisqali 200 mg daily dose tablets (21-unit package). This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. Kisqali (ribociclib) is a targeted cancer therapy commonly used in breast cancer treatment, reflecting the company's role in delivering specialized pharmaceutical products through DLA's medical supply chain. The SPE2DX contract vehicle enables AmerisourceBergen to fulfill pharmaceutical needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key provider within the Pentagon's healthcare logistics network.
Quick answers
Who was awarded contract SPE2DB25FCZKW?
SPE2DB25FCZKW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FCZKW worth?
The government has obligated $25,613 on SPE2DB25FCZKW.
Is contract SPE2DB25FCZKW an order under another contract?
Yes. SPE2DB25FCZKW is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCZKW competed?
The extent of competition for SPE2DB25FCZKW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award